Evidence map›Paper›PMID 41123310›Full record

ArticleBrain : a journal of neurology2026

Memory deficits of MDMA users are linked to cortical thinning related to 5-HT receptor densities.

Rebecca C Coray, Vincent Beliveau, Josua Zimmermann, Katrin H Preller, Michael Wunderli, Markus R Baumgartner, Erich Seifritz, Ann-Kathrin Stock, Christian Beste, David M Cole and 1 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Something is not nothing: Hair-tested substance use and cognitive functions in a large community sample of young adults.European psychiatry : the journal of the Association of European Psychiatrists · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rebecca C CorayExperimental Pharmacopsychology and Psychological Addiction Research, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, 8032 Zurich, Switzerland.ORCID 0000-0001-7775-6859
Vincent BeliveauNeurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, 2100 Copenhagen, Denmark.
Josua ZimmermannExperimental Pharmacopsychology and Psychological Addiction Research, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, 8032 Zurich, Switzerland.
Katrin H PrellerExperimental Pharmacopsychology and Psychological Addiction Research, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, 8032 Zurich, Switzerland.
Michael WunderliExperimental Pharmacopsychology and Psychological Addiction Research, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, 8032 Zurich, Switzerland.
Markus R BaumgartnerCenter for Forensic Hair Analytics, Institute of Forensic Medicine, University of Zurich, 8057 Zurich, Switzerland.
Erich SeifritzDepartment of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, 8032 Zurich, Switzerland.
Ann-Kathrin StockCognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, 01307 Dresden, Germany.
Christian BesteCognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, 01307 Dresden, Germany.
David M ColeExperimental Pharmacopsychology and Psychological Addiction Research, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, 8032 Zurich, Switzerland.
Boris B QuednowExperimental Pharmacopsychology and Psychological Addiction Research, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, 8032 Zurich, Switzerland.ORCID 0000-0001-7933-2865

Funding

German Research Foundation BE4045/34-1Swiss National Science Foundation 320030L_179450Swiss National Science Foundation PP00P1-123516Swiss National Science Foundation PP00P1-146326
6 · The paper itself

Abstract

Regular recreational use of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') has been consistently linked to verbal memory dysfunctions, whose neurobiological origins remain unclear. Although neurochemical, structural and functional alterations resulting from repeated MDMA intake have been identified in user populations, only limited knowledge exists regarding potential interrelationships among these components and their implications for mnemonic functions. The present study, thus, first examined the association of MDMA use with grey matter volume and cortical thickness. Subsequently, structural brain alterations were related to verbal memory performance and atlas-derived cerebral serotonin (5-HT) receptor expression patterns. Our data, involving 122 participants (61 MDMA users, 61 age-, sex- and education-matched MDMA-naive controls), revealed a robust reduction of grey matter volume within hippocampal regions and impaired verbal learning, short-term recall after interference, long-term recall and recognition performance in MDMA users compared with controls. Self-reported MDMA use in the past 6 months correlated with several memory performance scores. A moderate inverse correlation across all participants was observed between hippocampal volumes and verbal long-term memory. Correspondingly, hippocampal CA1 grey matter volume was related to MDMA use intensity in the last months as indicated by MDMA hair concentrations. The extent of cortical and subcortical grey matter differences between groups correlated with atlas-based 5-HT1A, 5-HT2A and 5-HT4 receptor densities, suggesting a serotonergic basis for mnemonic and structural alterations in MDMA users. Together, these findings highlight a multidimensional origin of memory dysfunction in MDMA users, where alterations in the chemoarchitecture of the brain may affect behaviour, possibly via influences on brain grey matter structures.

Indexed as

Cerebral CortexMemory DisordersN-Methyl-3,4-methylenedioxyamphetamineReceptors, SerotoninAdultFemaleGray MatterHippocampusHumansMagnetic Resonance ImagingMaleNeuropsychological TestsYoung AdultN-Methyl-3,4-methylenedioxyamphetamineReceptors, Serotoninamphetamine-type stimulantsecstasyempathogensentactogensneurotoxicityrecollection

Identifiers

PMID41123310
PMCPMC13058468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.